Which class of medication includes both aclidinium and formoterol?

Aclidinium and formoterol belong to the class of medications known as LAMA/LABA, which stands for Long-Acting Muscarinic Antagonist and Long-Acting Beta-Agonist. This class is essential in the management of chronic obstructive pulmonary disease (COPD) and asthma.

Aclidinium is a long-acting muscarinic antagonist that works by relaxing the airway muscles and opening the airways, making breathing easier. Formoterol, on the other hand, is a long-acting beta-agonist that stimulates beta-adrenergic receptors, leading to further bronchodilation. When used together, these medications provide complementary effects that improve lung function and control symptoms more effectively compared to using either medication alone.

The combination of aclidinium and formoterol helps provide extended relief from bronchospasms in patients with obstructive airway diseases. This makes the LAMA/LABA combination particularly valuable in providing sustained bronchodilation and improving respiratory function.